Document is current
Any future updates will be listed below
-
Authors
Nwosu, Amara Callistus
Stanley, Sarah
Mayland, Catriona R
Mason, Stephen
McDougall, Alexandra
Ellershaw, John E
-
Funding
Funding for this research was provided by:
Academy of Medical Sciences
UKH Foundation
Anne Duchess of Westminster Charity
Liverpool Clinical Commissioning Group
National Institute for Health Research (NIHR) North West Coast Clinical Research Network
Marie Curie
- License Information
-
More Information
Article History
Received: 21 March 2024
Accepted: 7 August 2024
First Online: 19 August 2024
Declarations
:
: Written consent was obtained from all study participants; this included consent to report individual patient data in publication. We used a research management strategy to ensure that the study was conducted safely for participants and reduced risk of harm and bias. Our study involved patient and public representatives, who helped to design the study, develop the study materials and support governance processes. Participant consent was recorded in a research recruitment log. All participants were provided with a copy of their consent forms. Ethics committee, North West - Haydock Ethics Research Ethics Committee, gave ethical approval for this work (REC: 17/NW/0050; IRAS ID: 196540). The study was registered with the Cancer Research UK Liverpool Cancer Trials Unit (LCTU). The LCTU was part of the Cancer Trials Research Centre which has UKCRC Clinical Trials Unit full registration, ensuring high standards of regulatory and quality control. The study was sponsored by the University of Liverpool. The researchers were independent from funders and sponsors. The sponsors and funder did not have access to the data or a role in the data analysis, results interpretation or writing the manuscript.
: Participants provided written consent for the publication of their research data in scientific manuscripts.
: The authors declare no competing interests.
